Celadon Pharmaceuticals

London, United Kingdom Founded: 2018 • Age: 8 yrs
Provider of cannabis trial services
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 3 Brand Intelligence

About Celadon Pharmaceuticals

Celadon Pharmaceuticals is a company based in London (United Kingdom) founded in 2018. Celadon Pharmaceuticals offers products and services including GMP Cannabis API and Cannabis-based Medicines. Celadon Pharmaceuticals operates in a competitive market with competitors including Ergomed and TTS Pharma, among others.

  • Headquarter London, United Kingdom
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Celadon Pharmaceuticals Plc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $2.51 M (USD), Post-IPO

    Dec 11, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Celadon Pharmaceuticals

Celadon Pharmaceuticals offers a comprehensive portfolio of products and services, including GMP Cannabis API and Cannabis-based Medicines.

Primary

Extracted active ingredient for cannabis-based medicines

Treatments for chronic pain and neurological conditions

Funding Insights of Celadon Pharmaceuticals

  • Total Funding
  • Total Rounds 1
  • Last Round Post-IPO — $2.5M
  • First Round

    (11 Dec 2023)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2023 Amount Post-IPO - Celadon Pharmaceuticals Valuation

investors

Investments & Acquisitions by Celadon Pharmaceuticals

Investments

Financial Statements - Celadon Pharmaceuticals

Celadon Pharmaceuticals Comparisons

+
Add Comparison
Available on Premium

Competitors of Celadon Pharmaceuticals

Celadon Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ergomed and TTS Pharma, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Full-service CRO operations are focused on oncology and complex trials.
domain founded_year HQ Location
TTS Pharma is engaged in producing high-quality, safe Cannabinoid products.

Latest news on Celadon Pharmaceuticals

Frequently Asked Questions about Celadon Pharmaceuticals

Celadon Pharmaceuticals was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Celadon Pharmaceuticals is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Celadon Pharmaceuticals was founded in 2018 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, with services centered on clinical trials for cannabis-based products. Support is offered to clients through trial management, regulatory compliance, and data analysis. The company serves the growing cannabis research market, ensuring adherence to UK and international standards for drug development.

Celadon Pharmaceuticals's top competitors include TTS Pharma and Ergomed.

Celadon Pharmaceuticals offers GMP Cannabis API and Cannabis-based Medicines.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available